Femasys Inc (FEMY) stock
FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/3016% below fair value
$1.40−0.10 (-6.67%)
Close on Nov 12, 2026Market cap $11.73MP/E –Yield –
Femasys EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Femasys's EPS for the twelve months ending Jun 30, 2026 was -$4.58. For fiscal 2025 it was -$9.40. The highest annual figure on record is -$9.40 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.40 | – |
| FY2024 | Dec 31, 2024 | -$17.00 | – |
| FY2023 | Dec 31, 2023 | -$18.60 | – |
| FY2022 | Dec 31, 2022 | -$19.20 | – |
| FY2021 | Dec 31, 2021 | -$22.40 | – |
| FY2020 | Dec 31, 2020 | -$144.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.33 | – |
| Q1 FY2026 | Mar 31, 2026 | $0.00 | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.25 | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.00 | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.18 | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.60 | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.49 | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.80 | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.20 | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.40 | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.12 | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.20 | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.40 | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.00 | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.89 | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.00 | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.40 | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.80 | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.80 | – |
| Q2 FY2021 | Jun 30, 2021 | -$10.40 | – |
| Q1 FY2021 | Mar 31, 2021 | -$36.80 | – |
| Q4 FY2020 | Dec 31, 2020 | -$34.10 | – |
| Q3 FY2020 | Sep 30, 2020 | -$32.80 | – |
| Q2 FY2020 | Jun 30, 2020 | -$31.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?